Corza Medical to acquire Takeda’s TachoSil manufacturing operations

Corza Medical entered into a definitive agreement with a subsidiary of Takeda Pharmaceuticals to acquire the TachoSil manufacturing operations in Linz, Austria. Corza Medical had previously acquired the commercial product rights for TachoSil, a surgical patch trusted by medical professionals worldwide, in January 2021. The acquisition of the TachoSil manufacturing operations will benefit customers and employees, as TachoSil’s experienced manufacturing teams and extensive production knowledge will be complemented by Corza Medical’s surgical focus, global commercial expertise, entrepreneurial culture, and infrastructure to scale for significant growth. The transaction, which is subject to the satisfaction of certain anti-trust and FDI customary regulatory approvals, is expected to close by the first quarter of 2024.